Mentioned On
Episode Mentions
Pharma and BioTech Daily · Apr 29, 2026
AstraZeneca's Breztri Asthma Approval Boosts $80B Goal | Pharma and Biotech Daily
“In royalty dispute with GSK over Gemperely, illustrating partnership and IP challenges”
FDA Drug Approval and RescissionData Integrity in Drug DevelopmentAI-Designed Therapeutics
View Analysis